Emerging roles of the metabolic regulator 3-hydroxy-3-methylglutaryl coenzyme-CoA reductase in human cancers: From biology to therapeutics. [PDF]
Li W +5 more
europepmc +1 more source
Ergosterol: Biological Activities, Mechanistic Evidence, Pharmacokinetic Barriers, and Delivery Strategies. [PDF]
Yao M +7 more
europepmc +1 more source
Rising antifungal resistance in <i>Trichophyton</i> species-the bleak future for treatment of dermatomycosis? [PDF]
Burmester A +5 more
europepmc +1 more source
Metabolic engineering of Phaeodactylum tricornutum for heterologous production of the plant triterpenoid friedelin. [PDF]
Nguyen K, Choi MS, Seo S, Song J, Jin E.
europepmc +1 more source
Developmental sterol biosynthesis inhibition: are prescription medications as safe as we think? [PDF]
Korade Z, Mirnics K.
europepmc +1 more source
The compound LY295427 antagonizes 25-hydroxycholesterol through binding to INSIG. [PDF]
Wen XY +8 more
europepmc +1 more source
Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities. [PDF]
Yu M +9 more
europepmc +1 more source
Engineering <i>Yarrowia lipolytica</i> for high-level ergosterol production. [PDF]
Liu X +7 more
europepmc +1 more source
Something Old Brings New Insights: Activity of Cerivastatin Against Thermally Dimorphic Fungi and Its Potential as an Antifungal Scaffold. [PDF]
Borba-Santos LP, Rozental S.
europepmc +1 more source
Cholesterol and steroid synthesis pathways may be involved in the inhibition of osteosarcoma cell viability by calcium-sensing receptor antagonism. [PDF]
Wang L +7 more
europepmc +1 more source

